BJP-Shiv Sena eye gains as Cong-NCP aim to hold fort in Western Maharashtra

Agencies
April 15, 2019

Mumbai, Apr 15: The prosperous, politically-dominant region of Western Maharashtra, which has seen a huge turmoil in recent weeks, is all set for edge-of-seat contest in its nine Lok Sabha constituencies here.

These are: Pune, Baramati, Madha, Sangli, Satara, Kolhapur and Hathkanangale that will vote in Phase III on April 23, and Maval and Shirur, where polling is in Phase IV on April 29.

Unawed by the `Modi wave` of 2014, the region conceded only two seats to the Bharatiya Janata Party (BJP), two to its ally Shiv Sena but gave four to the Nationalist Congress Party (NCP) and one to the Swabhimani Shetkari Sanghatana (SSS).

The elections will decide the political fate of some of the biggest political clans like the Pawars, the Mohite-Patils and the late Vasantrao `Dada` Patil`s family clawing to retain their stronghold as the ruling BJP attempts to bulldoze their supremacy.

For starters, the third generation Parth Pawar, son of former Deputy Chief Minister Ajit Pawar and grand-nephew of NCP supremo Sharad Pawar, is contesting from Maval, while his cousin-aunt Supriya Sule (Sharad Pawar`s daughter) is nominated from Baramati.

Parth is pitted against Shiv Sena`s sitting MP Shrirang C. Barne with the ally BJP Minister Chandrakant Patil vowing to chase away Parth from the battlefield.

In Baramati, the seat represented by Sharad Pawar for seven terms and Ajit Pawar for one term, Supriya Sule is making her third attempt amidst a loud chorus by the BJP that the "Pawars would be politically erased" from the region.

The BJP has pitted Kanchan Kul, making it only one of the two seats in the state - besides Mumbai North-Central - which will have a direct woman-to-woman contest, even as Prime Minister Narendra Modi and other BJP leaders launched a scathing attack on the Pawar clan.

In fact, Modi was scheduled to address a rally here on April 10, but it was cancelled at the last minute and now he`s expected to come next week to give a final push to Pawars` prospects.

In Shirur, there`s a dash of glamour in the form of television actor Amol Kolhe - famed for the roles of Chhatrapati Shivaji Maharaj and Chhatrapati Sambhaji Maharaj - contesting on an NCP ticket.

Interestingly, Kolhe had left the Shiv Sena to join the NCP two months ago and is now hoping to wrest the Shirur seat from the three-timer sitting Sena MP Shivajirao A. Patil.

Sangli has another tough contest coming up with the late Vasantrao Patil`s grandson, Vishal Prakashbapu Patil, entering the fray on an SSS ticket, as part of the Congress-NCP led 56-party Mahagathbandhan, pitted against the BJP`s sitting MP Sanjay `Kaka` Patil.

Vishal Prakashbapu Patil`s nomination sparked a family fued with his elder brother and former Union Minister Pratik Prakashbapu Patil qutting the Congress and politics.

The Satara seat has an interesting contest with the NCP`s two-time MP Udayanraje P. Bhosale, a direct descendent of Chhatrapati Shivaji Maharaj, locking horns with the BJP`s Narendra Annasaheb Patil, a former Shiv Sainik.

In Madha, the NCP dropped sitting MP Vijaysinh Mohite-Patil and denied a ticket to his son Ranjitsinh, who walked over to the BJP, but it has given the ticket to a royal descendent, Ranjitsinh Naik-Nimbalkar, who recently quit the Congress. He will lock horns with NCP nominee Sanjay Shinde, a bitter rival of the Mohite-Patils.

Pune will see state minister Girish Bapat contesting as a BJP candidate after the party dropped its sitting MP Anil Shirole. He will be challenged by Congress state General Secretary Mohan Joshi.

Hathkanangale will see two-time SSS MP Raju Shetti take on the Shiv Sena`s Dhairyasheel Mane, son of former NCP MP Nivedita Mane.

Western Maharashtra has several major sugar mills, Pune is regarded as the state`s cultural capital and the `Oxford of the East`, Solapur is famed for its textiles industries while Sangli is India`s turmeric capital.

Satara and Kolhapur are home to two of the biggest royal families in western India who are direct descendents of the Chhatrapatis.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 27,2020

New Delhi, Feb 27: Congress leader Priyanka Gandhi Vadra on Thursday attacked the government over the transfer of Delhi High Court Judge S Muralidhar, saying the Centre's attempts to "muzzle" justice and "break people's faith in an upright judiciary are deplorable".

Delhi HC Judge S Muralidhar was transferred to the Punjab and Haryana High Court, days after the Supreme Court collegium made the recommendation.

"The midnight transfer of Justice Muralidhar isn't shocking given the current dispensation, but it is certainly sad & shameful," Priyanka Gandhi tweeted. "Millions of Indians have faith in a resilient & upright judiciary, the government’s attempts to muzzle justice & break their faith are deplorable," she said.

The judge was hearing the Delhi violence case and the late evening notification came on the day when a bench headed by him expressed "anguish" over the Delhi Police's failure to register FIRs against alleged hate speeches by three BJP leaders.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 21,2020

New Delhi, Mar 21: Novel coronavirus cases in India rose to 258 on Saturday after 35 fresh cases were reported in various parts of the country, according to the Health Ministry.

Among the 258 are 39 foreign nationals, including 17 from Italy, three from the Philippines, two from the UK, one each belonging to Canada, Indonesia and Singapore.

The total figure also includes four deaths reported from Delhi, Karnataka, Punjab and Maharashtra.

"The total number of active COVID-19 cases across India stands at 231 so far," the ministry said, adding that 23 others have been cured/discharged/migrated while four have died.

Delhi has, so far, reported 26 positive cases, which include one foreigner, while Uttar Pradesh has recorded 24 cases, including one foreigner.

Maharashtra has 52 cases, including three foreigners, while Kerala has recorded 40 cases, which include seven foreign nationals.

Karnataka has 15 coronavirus patients. The number of cases in Ladakh rose to 13 and Jammu & Kashmir four. Telangana has reported 19 cases, which include 11 foreigners.

Rajasthan has also reported 17 cases, including two foreigners. Gujarat has reported seven cases so far.

Tamil Nadu, Andhra Pradesh and Uttarakhand have reported three cases each.

West Bengal, Odisha and Punjab each reported two cases while Puducherry, Chhattisgarh and Chandigarh reported one case each.

In Haryana, there are 17 cases, which include 14 foreigners.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.